# BlackSky Technology Inc.: financial statements, quarterly

BKSY · NYSE · CIK 1753539 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bksy.md) · [Financials](/companies/bksy/financials.md) · [Filings](/companies/bksy/filings.md) · [Insiders](/companies/bksy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bksy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.3](/filings/0001753539-24-000136.md) | [35.5 d](/filings/0001753539-25-000030.md) | [24.2](/filings/0001753539-25-000053.md) | [24.9](/filings/0001753539-25-000094.md) | [22.5](/filings/0001753539-25-000107.md) | [30.4 d](/filings/0001753539-26-000032.md) | [29.5](/filings/0001753539-26-000064.md) | [22.2](/filings/0001753539-26-000124.md) | [19.6](/filings/0001753539-25-000107.md) | [35.2 d](/filings/0001753539-26-000032.md) | [20.8](/filings/0001753539-26-000064.md) | [33.3](/filings/0001753539-26-000124.md) |
| Research and development | $m | [0.1](/filings/0001753539-24-000136.md) | [0.1 d](/filings/0001753539-25-000030.md) | [0.5](/filings/0001753539-25-000053.md) | [0.3](/filings/0001753539-25-000094.md) | [0.0](/filings/0001753539-25-000107.md) | [0.6 d](/filings/0001753539-26-000032.md) | [0.2](/filings/0001753539-26-000064.md) | [0.0](/filings/0001753539-26-000124.md) | [0.0](/filings/0001753539-25-000107.md) | [0.1 d](/filings/0001753539-26-000032.md) | [0.2](/filings/0001753539-26-000064.md) | [0.3](/filings/0001753539-26-000124.md) |
| Selling, general and administrative | $m | [17.6](/filings/0001753539-24-000136.md) | [17.3 d](/filings/0001753539-25-000030.md) | [18.8](/filings/0001753539-25-000053.md) | [18.2](/filings/0001753539-25-000094.md) | [18.0](/filings/0001753539-25-000107.md) | [19.1 d](/filings/0001753539-26-000032.md) | [21.4](/filings/0001753539-26-000064.md) | [22.7](/filings/0001753539-26-000124.md) | [21.7](/filings/0001753539-25-000107.md) | [21.6 d](/filings/0001753539-26-000032.md) | [22.6](/filings/0001753539-26-000064.md) | [23.8](/filings/0001753539-26-000124.md) |
| Operating income | $m | [(14.5)](/filings/0001753539-24-000136.md) | [(4.6) d](/filings/0001753539-25-000030.md) | [(13.3)](/filings/0001753539-25-000053.md) | [(11.7)](/filings/0001753539-25-000094.md) | [(13.2)](/filings/0001753539-25-000107.md) | [(6.1) d](/filings/0001753539-26-000032.md) | [(12.0)](/filings/0001753539-26-000064.md) | [(13.9)](/filings/0001753539-26-000124.md) | [(16.8)](/filings/0001753539-25-000107.md) | [(4.2) d](/filings/0001753539-26-000032.md) | [(18.5)](/filings/0001753539-26-000064.md) | [(7.8)](/filings/0001753539-26-000124.md) |
| Interest expense | $m | [2.5](/filings/0001753539-24-000136.md) | [2.7 d](/filings/0001753539-25-000030.md) | [2.6](/filings/0001753539-25-000053.md) | [3.0](/filings/0001753539-25-000094.md) | [3.1](/filings/0001753539-25-000107.md) | [3.4 d](/filings/0001753539-26-000032.md) | [3.3](/filings/0001753539-26-000064.md) | [3.5](/filings/0001753539-26-000124.md) | [4.0](/filings/0001753539-25-000107.md) | [4.1 d](/filings/0001753539-26-000032.md) | [3.9](/filings/0001753539-26-000064.md) | [3.9](/filings/0001753539-26-000124.md) |
| Income tax | $m | [0.1](/filings/0001753539-24-000136.md) | [0.4 d](/filings/0001753539-25-000030.md) | [0.1](/filings/0001753539-25-000053.md) | [0.3](/filings/0001753539-25-000094.md) | [0.0](/filings/0001753539-25-000107.md) | [0.0 d](/filings/0001753539-26-000032.md) | [0.0](/filings/0001753539-26-000064.md) | [0.0](/filings/0001753539-26-000124.md) | [0.0](/filings/0001753539-25-000107.md) | [0.0 d](/filings/0001753539-26-000032.md) | [0.0](/filings/0001753539-26-000064.md) | [0.0](/filings/0001753539-26-000124.md) |
| Net income | $m | [0.7](/filings/0001753539-24-000136.md) | [(3.8) d](/filings/0001753539-25-000030.md) | [(15.8)](/filings/0001753539-25-000107.md) | [(9.4)](/filings/0001753539-25-000107.md) | [(12.6)](/filings/0001753539-25-000107.md) | [(19.4) d](/filings/0001753539-26-000032.md) | [(12.8)](/filings/0001753539-26-000124.md) | [(41.2)](/filings/0001753539-26-000124.md) | [(15.3)](/filings/0001753539-25-000107.md) | [(0.9) d](/filings/0001753539-26-000032.md) | [(29.7)](/filings/0001753539-26-000124.md) | [(20.8)](/filings/0001753539-26-000124.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001753539-24-000136.md) | not reported | [(0.88)](/filings/0001753539-25-000053.md) | [(0.52)](/filings/0001753539-25-000094.md) | [(0.66)](/filings/0001753539-25-000107.md) | not reported | [(0.42)](/filings/0001753539-26-000064.md) | [(1.27)](/filings/0001753539-26-000124.md) | [(0.44)](/filings/0001753539-25-000107.md) | not reported | [(0.82)](/filings/0001753539-26-000064.md) | [(0.54)](/filings/0001753539-26-000124.md) |
| Basic EPS | $ per share | [0.04](/filings/0001753539-24-000136.md) | not reported | [(0.88)](/filings/0001753539-25-000053.md) | [(0.52)](/filings/0001753539-25-000094.md) | [(0.66)](/filings/0001753539-25-000107.md) | not reported | [(0.42)](/filings/0001753539-26-000064.md) | [(1.27)](/filings/0001753539-26-000124.md) | [(0.44)](/filings/0001753539-25-000107.md) | not reported | [(0.82)](/filings/0001753539-26-000064.md) | [(0.54)](/filings/0001753539-26-000124.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.1](/filings/0001753539-24-000136.md) | [32.8](/filings/0001753539-25-000030.md) | [15.0](/filings/0001753539-25-000053.md) | [25.6](/filings/0001753539-25-000094.md) | [56.2](/filings/0001753539-25-000107.md) | [13.1](/filings/0001753539-26-000032.md) | [20.7](/filings/0001753539-26-000064.md) | [22.6](/filings/0001753539-26-000124.md) | [28.8](/filings/0001753539-25-000107.md) | [42.4](/filings/0001753539-26-000124.md) | [39.4](/filings/0001753539-26-000064.md) | [36.9](/filings/0001753539-26-000124.md) |
| Current assets | $m | [70.7](/filings/0001753539-23-000102.md) | [79.3](/filings/0001753539-25-000030.md) | [69.4](/filings/0001753539-24-000063.md) | [82.4](/filings/0001753539-24-000095.md) | [107](/filings/0001753539-24-000136.md) | [107](/filings/0001753539-26-000032.md) | [121](/filings/0001753539-25-000053.md) | [139](/filings/0001753539-25-000094.md) | [201](/filings/0001753539-25-000107.md) | [207](/filings/0001753539-26-000124.md) | [185](/filings/0001753539-26-000064.md) | [310](/filings/0001753539-26-000124.md) |
| Total assets | $m | [213](/filings/0001753539-23-000102.md) | [224](/filings/0001753539-25-000030.md) | [210](/filings/0001753539-24-000063.md) | [224](/filings/0001753539-24-000095.md) | [245](/filings/0001753539-24-000136.md) | [254](/filings/0001753539-26-000032.md) | [285](/filings/0001753539-25-000053.md) | [311](/filings/0001753539-25-000094.md) | [381](/filings/0001753539-25-000107.md) | [386](/filings/0001753539-26-000124.md) | [372](/filings/0001753539-26-000064.md) | [517](/filings/0001753539-26-000124.md) |
| Current liabilities | $m | [18.7](/filings/0001753539-23-000102.md) | [27.5](/filings/0001753539-25-000030.md) | [17.3](/filings/0001753539-24-000063.md) | [19.7](/filings/0001753539-24-000095.md) | [18.8](/filings/0001753539-24-000136.md) | [26.0](/filings/0001753539-26-000032.md) | [32.0](/filings/0001753539-25-000053.md) | [37.4](/filings/0001753539-25-000094.md) | [51.7](/filings/0001753539-25-000107.md) | [59.5](/filings/0001753539-26-000124.md) | [53.6](/filings/0001753539-26-000064.md) | [53.1](/filings/0001753539-26-000124.md) |
| Total liabilities | $m | [121](/filings/0001753539-23-000102.md) | [131](/filings/0001753539-25-000030.md) | [128](/filings/0001753539-24-000063.md) | [148](/filings/0001753539-24-000095.md) | [135](/filings/0001753539-24-000136.md) | [160](/filings/0001753539-26-000032.md) | [196](/filings/0001753539-25-000053.md) | [224](/filings/0001753539-25-000094.md) | [290](/filings/0001753539-25-000107.md) | [291](/filings/0001753539-26-000124.md) | [291](/filings/0001753539-26-000064.md) | [305](/filings/0001753539-26-000124.md) |
| Long-term debt | $m | [79.5](/filings/0001753539-23-000102.md) | [83.5](/filings/0001753539-25-000030.md) | [84.7](/filings/0001753539-24-000063.md) | [108](/filings/0001753539-24-000095.md) | [98.4](/filings/0001753539-24-000136.md) | [106](/filings/0001753539-26-000032.md) | [112](/filings/0001753539-25-000053.md) | [117](/filings/0001753539-25-000094.md) | [189](/filings/0001753539-25-000107.md) | [193](/filings/0001753539-26-000124.md) | [193](/filings/0001753539-26-000064.md) | [199](/filings/0001753539-26-000124.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001753539-25-000030.md) | [0.3](/filings/0001753539-24-000063.md) | [0.3](/filings/0001753539-24-000095.md) | [0.3](/filings/0001753539-24-000136.md) | [1.9](/filings/0001753539-26-000032.md) | [3.8](/filings/0001753539-25-000053.md) | [5.2](/filings/0001753539-25-000094.md) | [5.8](/filings/0001753539-25-000107.md) | [7.9](/filings/0001753539-26-000124.md) | [9.3](/filings/0001753539-26-000064.md) | [11.7](/filings/0001753539-26-000124.md) |
| Shareholders' equity | $m | [92.1](/filings/0001753539-24-000136.md) | [93.2](/filings/0001753539-26-000032.md) | [81.7](/filings/0001753539-25-000107.md) | [76.5](/filings/0001753539-25-000107.md) | [110](/filings/0001753539-25-000107.md) | [94.0](/filings/0001753539-26-000124.md) | [88.8](/filings/0001753539-26-000124.md) | [86.6](/filings/0001753539-26-000124.md) | [91.1](/filings/0001753539-25-000107.md) | [94.9](/filings/0001753539-26-000124.md) | [80.8](/filings/0001753539-26-000124.md) | [212](/filings/0001753539-26-000124.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.2) d](/filings/0001753539-24-000136.md) | [(1.6) d](/filings/0001753539-25-000030.md) | [(3.8)](/filings/0001753539-25-000053.md) | [(1.8) d](/filings/0001753539-25-000094.md) | [1.0 d](/filings/0001753539-25-000107.md) | [(1.8) d](/filings/0001753539-26-000032.md) | [27.2](/filings/0001753539-26-000064.md) | [(7.3) d](/filings/0001753539-26-000124.md) | [(39.0) d](/filings/0001753539-25-000107.md) | [(9.3) d](/filings/0001753539-26-000032.md) | [(2.4)](/filings/0001753539-26-000064.md) | [(3.5) d](/filings/0001753539-26-000124.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q4 FY2023 (2023-03-31) | Q4 FY2023 (2023-06-30) | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [119](/filings/0001753539-23-000102.md) | [124](/filings/0001753539-24-000063.md) | [137](/filings/0001753539-24-000095.md) | [17.9](/filings/0001753539-24-000136.md) | [17.9](/filings/0001753539-25-000053.md) | [145](/filings/0001753539-24-000095.md) | [19.1](/filings/0001753539-25-000107.md) | [30.8](/filings/0001753539-26-000064.md) | [32.5](/filings/0001753539-26-000124.md) | [35.2](/filings/0001753539-25-000107.md) | [36.2](/filings/0001753539-26-000064.md) | [38.4](/filings/0001753539-26-000124.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 40,924,846 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001753539-26-000124.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.